openPR Logo
Press release

Josamycin and Pirarubicin China Market to Reach USD 512 Million by 2034

11-10-2025 01:20 PM CET | Associations & Organizations

Press release from: Exactitude Consultancy

Josamycin and Pirarubicin China Market

Josamycin and Pirarubicin China Market

Pune, India, November 2025 - According to a new report by Exactitude Consultancy, the China Josamycin and Pirarubicin Market is projected to grow from USD 290 million in 2024 to USD 512 million by 2034, registering a CAGR of 6.0% during the forecast period (2025-2034). The growth is fueled by the increasing use of macrolide antibiotics such as Josamycin in infectious disease management and rising demand for Pirarubicin, a key anthracycline chemotherapeutic, in oncology treatment protocols across China.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/47985

Key Takeaways
• Market Size 2024: USD 290 Million
• Forecast 2034: USD 512 Million
• CAGR (2025-2034): 6.0%
• Core Segments: Josamycin (Antibiotic) and Pirarubicin (Anticancer Drug)
• Key Drivers: Increasing Infection Rates, Expansion of Cancer Treatment Programs, and Growth of Local Pharmaceutical Manufacturing
• Primary Region: China (with export potential across APAC)
• Leading Companies: Chia Tai Tianqing Pharmaceutical, Zhejiang Hisun Pharmaceutical, CSPC Pharmaceutical Group, Harbin Pharmaceutical Group, Qilu Pharmaceutical, Shandong New Time Pharmaceutical, Yangtze River Pharmaceutical, Jiangsu Hengrui Medicine, Luoxin Pharmaceutical, Yabao Pharmaceutical

Market Story
The Josamycin and Pirarubicin market in China reflects the country's dual focus on infectious disease control and oncology innovation.
• Josamycin, a macrolide antibiotic derived from Streptomyces narbonensis, is gaining traction as a broad-spectrum antimicrobial agent with favorable resistance profiles compared to older macrolides. It is increasingly used in respiratory tract infections, sexually transmitted diseases, and skin infections.
• Pirarubicin, a derivative of doxorubicin, is witnessing growing adoption in chemotherapy regimens for breast, bladder, and hepatic cancers owing to its improved safety profile and reduced cardiotoxicity.

China's biopharmaceutical ecosystem-bolstered by government incentives for domestic drug innovation, rapid hospital network expansion, and low-cost production infrastructure-is propelling both segments toward robust growth through 2034.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/47985/josamycin-china-pirarubicin-china-market

Segmentation Overview
• By Drug Type:
Josamycin (Antibacterial), Pirarubicin (Anticancer)

• By Application:
Infectious Disease Treatment, Oncology (Solid Tumors, Hematologic Malignancies), Research Use

• By Distribution Channel:
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics

• By End User:
Hospitals, Cancer Treatment Centers, Research Institutions, Community Health Facilities

• By Region:
China (Domestic), Rest of Asia Pacific (Export Markets)

Recent Developments
• Jiangsu Hengrui Medicine: Expanded clinical trials for Pirarubicin combinations targeting breast and bladder cancer.
• CSPC Pharmaceutical Group: Scaled up Josamycin production with improved fermentation yields and quality controls.
• Qilu Pharmaceutical: Invested in advanced oncology drug manufacturing facilities meeting cGMP standards.
• Zhejiang Hisun Pharmaceutical: Strengthened supply chain resilience for antibiotics and oncology APIs amid global demand fluctuations.
• Yangtze River Pharmaceutical: Developed new formulation variants of Pirarubicin with reduced systemic toxicity.

Expert Insight
"The dual growth of Josamycin and Pirarubicin illustrates China's strong pharma diversification-from infectious disease control to oncology care. With local innovation and cost leadership, these drugs are positioned for global competitiveness," said Anurag Tiwari, Senior Pharmaceutical Industry Analyst at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=47985

Market Drivers
1. Rising Infection Prevalence: Urban pollution, antibiotic resistance, and respiratory disease spikes drive Josamycin usage.
2. Oncology Pipeline Expansion: Increasing cancer incidence and improved diagnostic rates support Pirarubicin demand.
3. Government Incentives: China's "Made in China 2025" and "Healthy China 2030" initiatives boost domestic drug development.
4. Hospital Infrastructure Growth: Rapid expansion of tertiary care centers increases accessibility to advanced treatments.
5. Export Potential: China's competitive manufacturing and API production capabilities are enhancing regional exports.

Forecast & Regional Insights
China dominates both segments due to its strong domestic consumption and growing export pipeline to neighboring Asian markets. The antibiotic sector benefits from high demand across primary healthcare facilities, while the oncology drug segment gains from state-supported cancer treatment programs.
By 2034, China's pharmaceutical market will increasingly focus on biosimilar oncology drugs, advanced antibiotic stewardship, and AI-integrated manufacturing systems, positioning the country as a key global supplier for Josamycin and Pirarubicin formulations.

Conclusion
The Josamycin and Pirarubicin Market in China embodies the nation's shift toward self-reliant pharmaceutical manufacturing and R&D-driven growth. As the country strengthens its clinical infrastructure and biomanufacturing ecosystem, both drugs are set to play pivotal roles in infectious disease management and cancer care innovation over the next decade.

This report is also available in the following languages : Japanese (ジョサマイシン中国とピラルビシン中国市場), Korean (중국 조사마이신 & 중국 피라루비신 시장), Chinese (交沙霉素中国市场和吡柔比星中国市场), French (Marché chinois de la josamycine et de la pirarubicine), German (Josamycin- und Pirarubicin-Markt in China), and Italian (Mercato cinese di Josamicina e Pirarubicina), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/47985

Our More Reports:

Fiber to The Home (FTTH) Market
https://exactitudeconsultancy.com/reports/47987/fiber-to-the-home-ftth-market

Pseudomonas Aeruginosa Infection Treatment Market
https://exactitudeconsultancy.com/reports/48003/pseudomonas-aeruginosa-infection-treatment-market

PVC Paste Resin Market
https://exactitudeconsultancy.com/reports/48005/pvc-paste-resin-market

Medical Wigs - Sectional Purchase Market
https://exactitudeconsultancy.com/reports/48014/medical-wigs-sectional-purchase-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Josamycin and Pirarubicin China Market to Reach USD 512 Million by 2034 here

News-ID: 4261956 • Views:

More Releases from Exactitude Consultancy

Far-Field Wireless Power Transmission Market to Reach USD 9.8 Billion by 2034, Expanding at ~16.3% CAGR
Far-Field Wireless Power Transmission Market to Reach USD 9.8 Billion by 2034, E …
Pune, India - Exactitude Consultancy The global Far-Field Wireless Power Transmission Market is witnessing significant growth, driven by rising demand for contactless power delivery solutions in consumer electronics, IoT devices, healthcare, and industrial applications. The market was valued at approximately USD 2.1 billion in 2024 and is projected to reach around USD 9.8 billion by 2034, growing at a compound annual growth rate (CAGR) of ~16.3% during 2025-2034. Far-field wireless power transmission
Osimertinib Drugs Market Expands Amid Rising Lung Cancer Prevalence and Targeted Therapy Adoption
Osimertinib Drugs Market Expands Amid Rising Lung Cancer Prevalence and Targeted …
Pune, India - Exactitude Consultancy - The global Osimertinib Drugs Market is witnessing strong growth due to increasing prevalence of non-small cell lung cancer (NSCLC) and rising adoption of targeted therapies. Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is widely used for treating EGFR mutation-positive NSCLC patients, offering improved survival and reduced side effects compared to earlier treatments. The emphasis on personalized medicine and the development of
System-in-Package (SiP) Technology Market Accelerates with Rising Demand for Miniaturized, High-Performance Electronics
System-in-Package (SiP) Technology Market Accelerates with Rising Demand for Min …
Pune, India - Exactitude Consultancy - The global System-in-Package (SiP) Technology Market is witnessing robust growth as demand surges for compact, energy-efficient, and high-performance electronic devices. SiP technology integrates multiple semiconductors and passive components within a single package, enabling smaller device footprints while enhancing functionality and performance. The proliferation of smartphones, wearable devices, IoT, automotive electronics, and AI-powered devices is significantly driving the adoption of SiP solutions worldwide. Download Full PDF Sample
Automotive Fleet Management Market to Reach USD 86.5 Billion by 2034
Automotive Fleet Management Market to Reach USD 86.5 Billion by 2034
Pune, India - Exactitude Consultancy The global Automotive Fleet Management Market is witnessing substantial growth as organizations increasingly adopt digital solutions to improve vehicle utilization, reduce operational costs, and enhance driver safety. The market was valued at approximately USD 32.8 billion in 2024 and is projected to reach around USD 86.5 billion by 2034, expanding at a CAGR of about 10.2% during the forecast period from 2025 to 2034. Automotive fleet management

All 5 Releases


More Releases for China

China fund establishment, China fund management,china investment management
Pandacu China is a leading financial institution that specializes in providing fund establishment and management services for domestic and international investors looking to invest in China. The company was founded in 2015 by a team of experienced finance professionals with a deep understanding of the Chinese market and a strong network of contacts in the investment industry. https://boomingfaucet.com/ China Fund Establishment Consultation E-mail:nolan@pandacuads.com Investing in China can be a complex and challenging process, and
China Finance Advisor, China Debt Finance Corporation,China Investment Corporati …
Investment bank is a financial institution that helps companies and governments raise capital by underwriting and issuing securities, and also provides advice on mergers and acquisitions, strategic investments, and other financial matters. Investment banks typically have a team of professionals with expertise in various areas such as corporate finance, securities underwriting, sales and trading, and market research. http://pandacuads.com/ China Investment Corporation Email:nolan@pandacuads.com Some of the main services provided by investment banks include: Underwriting: Investment banks
China Investment Bank, China Investment Consultant, China Investment Corporation …
Pandacu is a company that specializes in cross-border investment in China. The company was founded in china and has since grown to become one of the leading cross-border investment firms in China. Pandacu offers a wide range of services to its clients, including investment advisory, market research, due diligence, and post-investment support. http://pandacuads.com/ Investment banking consultant Email:nolan@pandacuads.com Cross-border investment in China can be a complex and challenging process, as the country has a unique
china construction company,china engineering company,china major bridge engineer …
List of Top 500 Chinese Construction Enterprises ranking https://gzwatches.cn/ Free engineering construction consultation Email:nolan@wholsale9.com Company Name province 1 China State Construction Corporation Limited Beijing 2 China Railway Corporation Limited Beijing 3 China Railway Construction Corporation Limited Beijing 4 Shanghai Weimengsi Construction Engineering Co., Ltd. Shanghai 5 China Communications Construction Group Co., Ltd. Beijing 6 China Power Construction Corporation Limited Beijing 7 China Energy Construction Group Co., Ltd. Beijing 8 Shanghai Construction Engineering Group Co., Ltd. Shanghai 9 Jiangsu Zhongnan Construction Industry Group Co., Ltd. Jiangsu 10 China Gezhouba Group Co., Ltd. Hubei 11 China National Chemical Engineering Co., Ltd. Beijing 12 Sinoma Group Co., Ltd. Beijing 13 Guangxi Construction Engineering Group Co., Ltd. Guangxi 14 Shanghai Urban
Forehead Thermometer Market Analysis (2019- 2025)| Microlife (China), Radiant (C …
This research study is one of the most detailed and accurate ones that solely focus on the global Forehead Thermometer market. It sheds light on critical factors that impact the growth of the global Forehead Thermometer market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Forehead Thermometer market. The authors of
Global Color Steel Tile Market 2017 - South China, East China, Southwest China, …
Color Steel Tile Market Research Report A market study based on the " Color Steel Tile Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Color Steel Tile Market 2017’. The research report analyses the historical as well as present performance of the worldwide Color Steel Tile industry, and makes predictions on the future status of Color Steel Tile market on the basis